ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $612 | -87.4% | 29,397 | -88.6% | 0.01% | -89.8% |
Q1 2023 | $4,841 | -99.4% | 257,237 | +360.0% | 0.06% | +555.6% |
Q2 2022 | $787,000 | -22.4% | 55,918 | +33.5% | 0.01% | +28.6% |
Q1 2022 | $1,014,000 | -67.7% | 41,898 | -68.8% | 0.01% | -61.1% |
Q4 2021 | $3,137,000 | +16.6% | 134,429 | +106.0% | 0.02% | -76.9% |
Q3 2020 | $2,691,000 | -41.7% | 65,259 | -31.5% | 0.08% | -43.9% |
Q2 2020 | $4,614,000 | – | 95,207 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |